FeesSafety
Pluang+

Ether ETFs see $1.2B outflows in October, hitting their worst month of 2025 amid slowing major buyers.

Market News
24 Oct 2026
Cointribune
View Source
Bearish
Ether ETFs see $1.2B outflows in October, hitting their worst month of 2025 amid slowing major buyers.

In October 2025, spot Ether ETFs experienced $1.2 billion in net outflows, marking their worst month of the year after strong inflows in August and September. This decline coincides with Bitmine nearing its self-imposed 5% supply cap, reducing its weekly Ether purchases significantly. Together, these two major demand drivers have slowed simultaneously, creating a supply gap that ongoing adoption flows have yet to fill. The future stability of Ether depends on renewed fund inflows or new large buyers stepping in as Bitmine approaches its purchase limit and ETFs continue to sell.

Ether ETFs net outflows in October 2025 totaled $1.2 billion, marking their worst month of the year. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Oct 24, 2026 22:21 WIB: out of 50 major cryptocurrencies, 3 rose and 46 fell. Notable movers include AAVE at Rp2.429.261 with a -8.72% change, DOT at Rp18.666 with -8.62%, and SNX at Rp3.535 with -8.42%.

More News

Canada's Royal Canadian Legion launches 2026 Poppy Campaign with new contactless donations and a commemorative mural.

Canada's Royal Canadian Legion launches 2026 Poppy Campaign with new contactless donations and a commemorative mural.

The Royal Canadian Legion has launched its 2026 National Poppy Campaign introducing a new contactless donation method using smartphones, supported by BMO and Toucan Giving technology. This innovation allows volunteers to collect donations via debit, ...

Others
Bullish
2 hours ago
XBiotech appoints Jan-Paul Simard as Co-CEO alongside Sushma Shivaswamy to strengthen leadership.

XBiotech appoints Jan-Paul Simard as Co-CEO alongside Sushma Shivaswamy to strengthen leadership.

XBiotech Inc. announced the election of Jan-Paul Simard as Co-Chief Executive Officer alongside current CEO Dr. Sushma Shivaswamy, effective October 23, 2026. This leadership change aims to leverage their complementary skills and scientific expertise...

Market News
Bullish
3 hours ago
XBiotech appoints Sushma Shivaswamy and Jan-Paul Simard as co-CEOs to lead antibody therapy development.

XBiotech appoints Sushma Shivaswamy and Jan-Paul Simard as co-CEOs to lead antibody therapy development.

XBiotech Inc. announced the appointment of Sushma Shivaswamy and Jan-Paul Simard as co-chief executive officers, effective October 23, 2026. Shivaswamy, with 17 years at the company, has led scientific operations and was interim CEO since December 20...

Market News
Bullish
3 hours ago
Vertiv's Q3 report on Oct 28 will prove if delayed AI projects justify its valuation amid a 22% stock drop.

Vertiv's Q3 report on Oct 28 will prove if delayed AI projects justify its valuation amid a 22% stock drop.

Vertiv reports its Q3 2026 earnings on October 28 amid a 22% stock decline over the past month. Despite strong Q2 results with record profits and raised guidance, the stock has fallen due to concerns over delayed AI projects and supply chain issues. ...

Company Fundamentals
Neutral
4 hours ago
Bitcoin drops below $80,000 amid U.S. evacuations in Middle East over Iran threats

Bitcoin drops below $80,000 amid U.S. evacuations in Middle East over Iran threats

Bitcoin fell to its lowest level in over a month, slipping below $80,000, as the U.S. rapidly evacuated personnel from Middle Eastern embassies and military bases due to heightened threats of Iranian attacks. Intelligence reports indicate Iran is adv...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App